Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
541.08
-1.53 (-0.28%)
At close: Sep 4, 2026, 4:00 PM EDT
541.33
+0.25 (0.05%)
After-hours: Sep 4, 2026, 7:30 PM EDT
Madrigal Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $612 | Buy | Reiterates | $612 | +13.11% | Aug 12, 2026 |
| Wolfe Research | Wolfe Research | Buy Upgrades $605 | Buy | Upgrades | $605 | +11.81% | Aug 4, 2026 |
| Barclays | Barclays | Buy Maintains $964 → $962 | Buy | Maintains | $964 → $962 | +77.79% | Aug 3, 2026 |
Unknown Analyst B. Riley Securities No rating | B. Riley Securities | Buy Initiates $670 | Buy | Initiates | $670 | +23.83% | Jul 31, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates $709 | Buy | Reiterates | $709 | +31.03% | Jul 31, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $620 | Buy | Reiterates | $620 | +14.59% | Jul 31, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Reiterates $553 → $543 | Hold | Reiterates | $553 → $543 | +0.35% | Jul 31, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $644 | Buy | Maintains | $644 | +19.02% | Jul 31, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.